Works matching IS 09255710 AND DT 2023 AND VI 117 AND IP 3


Results: 21
    1
    2
    3
    4
    5
    6
    7

    Recent progress in ITP treatment.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 3, p. 316, doi. 10.1007/s12185-022-03527-1
    By:
    • Rodeghiero, Francesco
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 3, p. 366, doi. 10.1007/s12185-022-03495-6
    By:
    • Miyakawa, Yoshitaka;
    • Imada, Kazunori;
    • Ichikawa, Satoshi;
    • Uchiyama, Hitoji;
    • Ueda, Yasunori;
    • Yonezawa, Akihito;
    • Fujitani, Shigeki;
    • Ogawa, Yoshiyuki;
    • Matsushita, Tadashi;
    • Asakura, Hidesaku;
    • Nishio, Kenji;
    • Suzuki, Kodai;
    • Hashimoto, Yasuhiro;
    • Murakami, Hidenori;
    • Tahara, Sayaka;
    • Tanaka, Tomoyuki;
    • Matsumoto, Masanori
    Publication type:
    Article
    14

    A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 3, p. 409, doi. 10.1007/s12185-022-03494-7
    By:
    • Kato, Koji;
    • Fujii, Nobuharu;
    • Makita, Shinichi;
    • Goto, Hideki;
    • Kanda, Junya;
    • Shimada, Kazuyuki;
    • Akashi, Koichi;
    • Izutsu, Koji;
    • Teshima, Takanori;
    • Fukuda, Natsuko;
    • Sumitani, Tokuhito;
    • Nakamura, Shota;
    • Sumi, Hiroyuki;
    • Shimizu, Shinji;
    • Kakurai, Yasuyuki;
    • Yoshikawa, Kenji;
    • Tobinai, Kensei;
    • Usui, Noriko;
    • Hatake, Kiyohiko
    Publication type:
    Article
    15
    16

    Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 3, p. 421, doi. 10.1007/s12185-022-03489-4
    By:
    • Yanagisawa, Ryu;
    • Hirakawa, Tsuneaki;
    • Doki, Noriko;
    • Ikegame, Kazuhiro;
    • Matsuoka, Ken-ichi;
    • Fukuda, Takahiro;
    • Nakamae, Hirohisa;
    • Ota, Shuichi;
    • Hiramoto, Nobuhiro;
    • Ishikawa, Jun;
    • Ara, Takahide;
    • Tanaka, Masatsugu;
    • Koga, Yuhki;
    • Kawakita, Toshiro;
    • Maruyama, Yumiko;
    • Kanda, Yoshinobu;
    • Hino, Masayuki;
    • Atsuta, Yoshiko;
    • Yabe, Hiromasa;
    • Tsukada, Nobuhiro
    Publication type:
    Article
    17

    Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 3, p. 388, doi. 10.1007/s12185-022-03488-5
    By:
    • Oliveira, Ana C.;
    • Roncero, Josep Maria;
    • Ferrá, Christelle;
    • Do Nascimento, Janilson;
    • Rodriguez-Luaces, Marta;
    • Encuentra, Maite;
    • Domingo-Domenech, Eva;
    • López, Patricia;
    • Gallardo, David;
    • Ribera, Josep Maria;
    • Sarrá, Josep;
    • Sureda, Anna;
    • González-Barca, Eva
    Publication type:
    Article
    18
    19

    Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 3, p. 398, doi. 10.1007/s12185-022-03486-7
    By:
    • Yanada, Masamitsu;
    • Yamasaki, Satoshi;
    • Konuma, Takaaki;
    • Mizuno, Shohei;
    • Uchida, Naoyuki;
    • Onai, Daishi;
    • Fukuda, Takahiro;
    • Tanaka, Masatsugu;
    • Ozawa, Yukiyasu;
    • Eto, Tetsuya;
    • Ikegame, Kazuhiro;
    • Sawa, Masashi;
    • Katayama, Yuta;
    • Kawakita, Toshiro;
    • Onizuka, Makoto;
    • Kanda, Yoshinobu;
    • Ichinohe, Tatsuo;
    • Atsuta, Yoshiko;
    • Yano, Shingo
    Publication type:
    Article
    20
    21